Evidence map›Paper›PMID 25506011›Full record

ArticleCase reports in oncological medicine2014

Metastatic Basal cell carcinoma accompanying gorlin syndrome.

Yeliz Bilir, Erkan Gokce, Banu Ozturk, Faik Alev Deresoy, Ruken Yuksekkaya, Emel Yaman

Open access · goldAbstract read
In one paragraph

Article in Case reports in oncological medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yeliz BilirDepartment of Internal Diseases, Faculty of Medicine, Gaziosmanpaşa University, 60100 Tokat, Turkey.
Erkan GokceDepartment of Radiodiagnostics, Faculty of Medicine, Gaziosmanpaşa University, 60100 Tokat, Turkey.
Banu OzturkDivision of Medical Oncology, Faculty of Medicine, Gaziosmanpaşa University, 60100 Tokat, Turkey.
Faik Alev DeresoyDepartment of Pathology, Faculty of Medicine, Gaziosmanpaşa University, 60100 Tokat, Turkey.
Ruken YuksekkayaDepartment of Radiodiagnostics, Faculty of Medicine, Gaziosmanpaşa University, 60100 Tokat, Turkey.
Emel YamanDepartment of Medical Oncology, Faculty of Medicine, Mersin University, 33343 Mersin, Turkey.
Tokat Gaziosmanpaşa Üniversitesi · TRMersin Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gorlin-Goltz syndrome or basal cell nevus syndrome is an autosomal dominant syndrome characterized by skeletal anomalies, numerous cysts observed in the jaw, and multiple basal cell carcinoma of the skin, which may be accompanied by falx cerebri calcification. Basal cell carcinoma is the most commonly skin tumor with slow clinical course and low metastatic potential. Its concomitance with Gorlin syndrome, resulting from a mutation in a tumor suppressor gene, may substantially change morbidity and mortality. A 66-year-old male patient with a history of recurrent basal cell carcinoma was presented with exophthalmus in the left eye and the lesions localized in the left lateral orbita and left zygomatic area. His physical examination revealed hearing loss, gapped teeth, highly arched palate, and frontal prominence. Left orbital mass, cystic masses at frontal and ethmoidal sinuses, and multiple pulmonary nodules were detected at CT scans. Basal cell carcinoma was diagnosed from biopsy of ethmoid sinus. Based on the clinical and typical radiological characteristics (falx cerebri calcification, bifid costa, and odontogenic cysts), the patient was diagnosed with metastatic skin basal cell carcinoma accompanied by Gorlin syndrome. Our case is a basal cell carcinoma with aggressive course accompanying a rarely seen syndrome.

Identifiers

PMID25506011
PMCPMC4258375
OpenAlexW2039034198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.